Symbols

Symbols

MRUS

MRUS

Merger Investigation Underway for MRUS, HSII, PRO, and PBBK Shareholders

Saturday Oct 25, 2025

Merus Announces Positive Phase 2 Data for Petosemtamab in mCRC

Preliminary Data Shows Promising Activity of Petosemtamab in Metastatic Colorectal Cancer

Friday Oct 24, 2025

Merus Presents Positive Petosemtamab Data in Metastatic Colorectal Cancer.

Merus Reports Promising Petosemtamab Data in Metastatic Colorectal Cancer

Tuesday Oct 21, 2025

Shareholders of FSFG, MTSR, VRNT, MRUS Investigated for Potential Violations of Federal Securities Laws and Breaches of Fiduciary Duties

Genmab Launches Cash Tender Offer for Merus Common Shares at $97.00 per Share

Genmab offers $97 per share to acquire Merus in cash.

Monday Oct 20, 2025

Genmab's 15-minute chart: MACD Death Cross and KDJ Death Cross observed.

Friday Oct 17, 2025

KAIST Researchers Develop AI Technology to Predict Cell Responses to Drugs and Genetic Changes

Thursday Oct 16, 2025

Merus 15min chart triggers Bollinger Bands Expanding Downward, Bearish Marubozu

Tuesday Oct 14, 2025

Merus (MRUS) Shares Positive Phase 2 Cancer Trial Results Amid Financial Challenges

Merus Announces Presentation of Petosemtamab Abstract at AACR-NCI-EORTC International Conference

Merus' Petosemtamab Demonstrates Antitumor Activity and Manageable Safety Profile

Monday Oct 13, 2025

Merus to Present Petosemtamab Data at AACR-NCI-EORTC Conference

Merus's 15min chart triggers KDJ Death Cross, Bearish Marubozu indication.

Wednesday Oct 08, 2025

Merus's 15min chart signals MACD Death Cross and KDJ Death Cross.

Tuesday Oct 07, 2025

Halper Sadeh investigates potential violations of federal securities laws in 3 companies.

Monday Oct 06, 2025

Genmab's 15min chart sees Bollinger Bands narrowing, KDJ death cross confirmed.

Leerink Partners Downgrades Merus to Market Perform from Outperform, PT Raised to $97